Serum levels of 25-hydroxyvitamin D and interleukin-1β in Helicobacter pylori-infected women with postmenopausal osteoporosis

Dysfunction of the gastrointestinal system in Helicobacter pylori lesions significantly reduces the absorption of not only calcium (Ca), but also vitamin D and other nutrients, the intake of which is critical for bone formation. H. pylory can contribute to the formation of osteoporosis and due to the development of the inflammatory process. The inflammatory process is an important component of the pathogenesis of the above bone disease. Objective: to study of the levels of 25(OH)D and interleukin-1β in blood serum in postmenopausal OP in women with a positive test for antibodies to the Helicobacter pylori CagA antigen. Materials and methods. The study included 250 postmenopausal women, whose indicators (Me [Q1; Q3]) were 62 [56; 68] years, and the duration of the postmenopausal period is 13 [7; 20] years. In all patients, the content of 25(OH)D and interleukin-1β (IL-1β) concentrations were determined in blood serum samples. And total antibodies (IgA, IgM, IgG) to the CagA antigen of the pathogen Helicobacter pylori. Results. In the female group with postmenopausal osteoporosis, the presence of helicobacteriosis is associated with a decrease in the level of 25-hydroxyvitamin D in the blood serum by 14.8% (p=0.045). Serum IL-1β values in postmenopausal women do not depend on H. pylori infection (p>0.05). A negative correlation was found between the values of 25(OH)D and IL-1β in women with osteoporosis and a positive test for total antibodies to H. pylori (rs=-0.25; p<0.05). Conclusion. The results of the study demonstrate that the decrease in vitamin D depends on the infection with Helicobacter pylori in women with postmenopausal osteoporosis (p=0.045). The results of the studies obtained can be used in the diagnostic and treatment-and-prophylactic measures for women in the postmenopausal period.

1. Malfertheiner P., Venerito M., Schulz C. Helicobacter pylori Infection: New Facts in Clinical Management. Curr Treat Options Gastroenterol. 2018;16(4):605-615. DOI: 10.1007/s11938-018-0209-8.

2. Maylyan E.A., Zhadan E.S. Epidemiology of Helicobacter pylori. Vestnik of Hygiene and Epidemiology. 2022;26(2):171-179 (in Russ.). EDN: XALLMN.

3. Crowe S.E. Helicobacter pylori. N Engl J Med. 2019;380(12):1158-1165. DOI: 10.1056/NEJMcp1710945.

4. Gravina A.G., Zagari R.M., De Musis C., Romano L., Loguercio, C., Romano M. Helicobacter pylori and extragastric diseases: A review. World J Gastroenterol. 2018;24(29):3204-3221. DOI: 10.3748/wjg.v24.i29.3204.

5. Robinson K., Atherton J.C. The Spectrum of Helicobacter. Annu Rev Pathol. 2021;16:123-144. DOI: 10.1146/annurev-pathol-032520-024949.

6. Merlotti D., Mingiano C., Valenti R., Cavati G., Calabrese M., Pirrotta F., Bianciardi S., Palazzuoli A., et al. Bone Fragility in Gastrointestinal Disorders.Int J Mol Sci. 2022;23(5):2713. DOI: 10.3390/ijms23052713.

7. Lanets I.E., Gostischeva E.V. Modern views on the role of vitamin D in the human body. Scientific review. Medical sciences. 2022;(5):39-45 (in Russ.). EDN: KQCCRD.

8. Marino R., Misra M. Extra-Skeletal Effects of Vitamin D. Nutrients. 2019;11(7):1460. DOI: 10.3390/nu11071460.

9. Bouillon R. Extra-Skeletal Effects of Vitamin D. Front Horm Res. 2018;50:72-88. DOI: 10.1159/000486072.

10. Shafrir A., Shauly-Aharonov M., Katz L.H., Paltiel O., Pickman Y., Ackerman Z. The Association between Serum Vitamin D Levels and Helicobacter pylori. Nutrients. 2021;13(1):278. DOI: 10.3390/nu13010278.

11. Mut Surmeli D., Surmeli Z.G., Bahsi R., Turgut T., Selvi Oztorun H., Atmis V., Varli M., Aras S. Vitamin D deficiency and risk of Helicobacter pylori infection in older adults: a cross-sectional study. Aging Clin Exp Res. 2019;31(7):985-991. DOI: 10.1007/s40520-018-1039-1.

12. Yildirim O., Yildirim T., Seckin Y., Osanmaz P., Bilgic Y., Mete R. The influence of vitamin D deficiency on eradication rates of Helicobacter pylori. Adv Clin Exp Med. 2017;26(9):1377-1381. DOI: 10.17219/acem/65430.

13. Kim T.J., Lee H., Min Y.W., Min B.H., Lee J.H., Rhee P.L., Kim J.J. Cohort study of Helicobacter pylori infection and the risk of incident osteoporosis in women. J Gastroenterol Hepatol. 2021;36(3):657-663. DOI: 10.1111/jgh.15181.

14. Massironi S., Cavalcoli F., Zilli A., Del Gobbo A., Ciafardini C., Bernasconi S., Felicetta I., Conte D., et al. Relevance of vitamin D deficiency in patients with chronic autoimmune atrophic gastritis: a prospective study. BMC Gastroenterol. 2018;18(1):172. DOI: 10.1186/s12876-018-0901-0.

15. Christakos S., Dhawan P., Verstuyf A., Verlinden L., Carmeliet G. Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. Physiol Rev. 2016;96(1):365-408. DOI: 10.1152/physrev.00014.2015.

16. Pero R., Coretti L., Nigro E., Lembo F., Laneri S., Lombardo B., Daniele A., Scudiero O. β-Defensins in the Fight against Helicobacter pylori. Molecules. 2017;22(3):424. DOI: 10.3390/molecules22030424.

17. Dankers W., Colin E.M., van Hamburg J.P., Lubberts E. Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential. Front Immunol. 2017;7:697. DOI: 10.3389/fimmu.2016.00697.

18. Ignatenko G.A., Nemsadze I.G., Mirovich E.D., Churilov A.V., Maylyan E.A., Glazkov, A.E., Rumyantseva Z.S. The role of cytokines in bone remodeling and pathogenesis of postmenopausal osteoporosis. Medical Herald of the South of Russia. 2020;11(2):6-18 (in Russ.). DOI: 10.21886/2219-8075-2020-11-2-6-18. EDN: JLMNIV.

19. Ignatenko G.A. Mylyan E.A. Nemsadze I.G., Rumyantseva Z.S., Churilov A.V. Glazkov I.S. It's Mirovich.D. The role of cytokines in bone tissue remodeling in norm and pathology. Tavricheskiy mediko-biologicheskiy vestnik. 2020);23(1):133-139 (in Russ.). DOI: 10.37279/2070-8092-2020-23-1-133-139. EDN: PCVJAI.

20. Figueiredo C.A, Marques C.R, Costa Rdos S., da Silva H.B., Alcantara-Neves N.M. Cytokines, cytokine gene polymorphisms and Helicobacter pylori infection: friend or foe? World J Gastroenterol. 2014;20(18):5235-5243. DOI: 10.3748/wjg.v20.i18.5235.